Neuroprogression and episode recurrence in bipolar I disorder: A study of gray matter volume changes in first-episode mania and association with clinical outcome

Bipolar Disorders

Volumn 18, Issue 6, 2016, Pages 511-519

  Kozicky, Jan Marie ^a   McGirr, Alexander ^a   Bond, David J ^a,b   Gonzalez, Marjorie ^c   Silveira, Leonardo E ^a,d   Keramatian, Kamyar ^a   Torres, Ivan J ^a,e   Lam, Raymond W ^a   Yatham, Lakshmi N ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VANCOUVER COASTAL HEALTH   (Canada)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e British Columbia Mental Health Addiction Services   (Canada)

Author keywords

bipolar disorder; first episode mania; longitudinal; MRI; Neuroprogression; Recovery; VBM

Indexed keywords

ANTIDEPRESSANT AGENT; LITHIUM; LOXAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR I DISORDER; CLINICAL ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; LEFT FRONTAL REGION; LEFT PARIETAL REGION; MALE; MANIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; TEMPORAL LOBE; VOXEL BASED MORPHOMETRY; BIPOLAR DISORDER; DIAGNOSTIC IMAGING; EMOTION; FOLLOW UP; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PATIENT CARE; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; SECONDARY PREVENTION;

ADULT; BIPOLAR DISORDER; DISEASE PROGRESSION; EMOTIONS; EPISODE OF CARE; FEMALE; FOLLOW-UP STUDIES; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; ORGAN SIZE; PROSPECTIVE STUDIES; SECONDARY PREVENTION;

EID: 84991717418     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12437     Document Type: Article

References (37)

1. Vieta E, Reinares M, Rosa AR. Staging bipolar disorder. Neurotox Res. 2011;19(2):279–285.
2. Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd ed. New York: Oxford University Press; 2007.
3. Treuer T, Tohen M. Predicting the course and outcome of bipolar disorder: a review. European Psychiatry. 2010;25(6):328–333.
4. Goldberg JF, Garno JL, Harrow M. Long-term remission and recovery in bipolar disorder: a review. Current Psychiatry Reports. 2005;7(6):456–461.
5. Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania. J Clin Psychiatry. 2010;71(3):255–261.
6. Kessing LV, Hansen HV, Christensen EM, et al. Do young adults with bipolar disorder benefit from early intervention? J Affect Disord. 2014;152:403–408.
7. Yatham LN, Kauer-Sant'Anna M, Bond DJ, Lam RW, Torres I. Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the systematic treatment optimization program for early mania project. Can J Psychiatry-Revue Canadienne De Psychiatrie. 2009;54(2):105–112.
8. Kozicky J, Torres IJ, Silveira LE, Bond DJ, Lam RW, Yatham LN. Cognitive change in the year following a first manic episode: association with illness progression. J Clin Psych. 2014; 75, e587–e593.
9. Kauer-Sant'Anna M, Bond DJ, Lam RW, Yatham LN. Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the systematic treatment optimization program for early mania project. Compr Psychiatry. 2009;50(1):1–8.
10. Michalak EE, Torres IJ, Bond DJ, Lam RW, Yatham LN. The relationship between clinical outcomes and quality of life in first-episode mania: a longitudinal analysis. Bipolar Disord. 2013;15:188–198.
11. Phillips ML, Swartz HA. A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research. Am J Psychiatry. 2014;171(8):829–843.
12. Post RM. Mechanisms of illness progression in the recurrent affective disorders. Neurotox Res 2010;18:256–271.
13. Kapczinski F, Vieta E, Andreazza AC, et al. Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev. 2008;32:675–692.
14. Ashburner J, Friston KJ. Voxel-based morphometry – the methods. NeuroImage. 2000;11(6):805–821.
15. Bora E, Fornito A, Yucel M, Pantelis C. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry. 2010;67:1097–1105.
16. Selvaraj S, Arnone D, Job D, et al. Grey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studies. Bipolar Disord. 2012;14:135–145.
17. de Castro-Manglano P, Mechelli A, Soutullo C, Gimenez-Amaya J, Ortuno F, McGuire P. Longitudinal changes in brain structure following the first episode of psychosis. Psychiatry Res-Neuroimaging. 2011;191(3):166–173.
18. Arango C, Rapado-Castro M, Reig S, et al. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry. 2012;69(1):16–26.
19. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11:225–255.
20. Baitz HA, Thornton AE, Procyshyn RM, et al. Antipsychotic medications: linking receptor antagonism to neuropsychological functioning in first episode psychosis. J Int Neuropsychol Soc. 2012;18:717–727.
21. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage. 2003;19:1233–1239.
22. Lisy ME, Jarvis KB, DelBello MP, et al. Progressive neurostructural changes in adolescent and adult patients with bipolar disorder. Bipolar Disord. 2011;13:396–405.
23. Brooks JO, Foland-Ross LC, Thompson PM, Altshuler LL. Preliminary evidence of within-subject changes in gray matter density associated with remission of bipolar depression. Psychiatry Research-Neuroimaging. 2011;193(1):53–55.
24. van Haren NEM, Pol HEH, Schnack HG, et al. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry. 2008;63:106–113.
25. Schaufelberger MS, Lappin JM, Duran FLS, et al. Lack of progression of brain abnormalities in first-episode psychosis: a longitudinal magnetic resonance imaging study. Psychol Med. 2011;41:1677–1689.
26. Lim CS, Baldessarini RJ, Vieta E, Yucel M, Bora E, Sim K. Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev. 2013;37:418–435.
27. Lyoo IK, Kim MJ, Stoll AL, et al. Frontal lobe gray matter density decreases in bipolar I disorder. Biol Psychiatry. 2004;55:648–651.
28. Ekman CJ, Lind J, Ryden E, Ingvar M, Landen M. Manic episodes are associated with grey matter volume reduction – a voxel-based morphometry brain analysis. Acta PsychiatricaScandinavica. 2010;122:507–515.
29. Kauer-Sant'Anna M, Kapczinski F, Andreazza AC et al. Brain derived neurotrophic factor and inflammatory markers in patients with early- vs. late stage bipolar disorder. Int J Neuropsychopharmacol 2009; 12:447–458
30. Hafeman DM, Chang KD, Garrett AS, Sanders EM, Phillips ML. Effects of medication on neuroimaging findings in bipolar disorder: an updated review. Bipolar Disord. 2012;14:375–410.
31. Ho B-C, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry. 2011;68:128–137.
32. Andreasen NC, Liu DW, Ziebell S, Vora A, Ho BC. Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal mri study. Am J Psychiatry. 2013;170:609–615.
33. Leung M, Cheung C, Yu K, et al. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. anatomical likelihood estimation meta-analyses with sample size weighting. Schizophr Bull. 2011;37:199–211.
34. Radua J, Borgwardt S, Crescini A, et al. Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. Neurosci Biobehav Rev. 2012;36:2325–2333.
35. Nery FG, Matsuo K, Nicoletti MA, et al. Association between prior alcohol use disorders and decreased prefrontal gray matter volumes in bipolar I disorder patients. Neurosci Lett. 2011;503(2):136–140.
36. Jarvis K, DelBello MP, Mills N, Elman I, Strakowski SM, Adler CM. Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders. J Child Adolesc Psychopharmacol. 2008;18(6):557–563.
37. Blumberg HP, Krystal JH, Bansal R, et al. Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry. 2006;59:611–618.